Capricor Therapeutics has presented positive long-term data from its HOPE-2 clinical trial at the 2025 Muscular Dystrophy Association Conference, indicating that its leading treatment, deramiocel, can ...

From imaging innovations to new treatment approvals, 2024 brought advancements in Duchenne muscular dystrophy care and research. This year’s top stories on Duchenne muscular dystrophy (DMD) managed ...

Economic Impact of Disease Progression Disease progression stages and burden in patients with Duchenne muscular dystrophy using administrative claims supplemented by electronic medical records ...

LEIDEN, THE NETHERLANDS, GAINESVILLE, FL, AND NEW YORK, NY, CA / ACCESS Newswire / October 16, 2025 / In a major advancement for Duchenne muscular dystrophy (DMD) research and patient care, a ...

Please provide your email address to receive an email when new articles are posted on . Emflaza, a corticosteroid, improved or stabilized disease progression in most patients with Duchenne muscular ...

Please provide your email address to receive an email when new articles are posted on . Viltolarsen preserved muscle function over 2 years and delayed progression of Duchenne muscular dystrophy over 4 ...

As Avidity Biosciences Inc. brought the second-largest follow-on offering of the year to the market, the company also released positive early and midstage stage results of del-zota, an ...

Researchers at UBC’s School of Biomedical Engineering have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy. Duchenne muscular dystrophy (DMD) is a ...

New research recommends daily steroid doses for children with Duchenne muscular dystrophy, marking a significant change in how the disease is treated. New research published in JAMA recommends daily ...

There are many kinds of muscular dystrophies, which are caused by genetic mutations. These diseases reduce mobility, and complicate everyday tasks. Various types of muscular dystrophies can affect ...